Ingevity Corporation

NYSE:NGVT

Chemicals - Specialty

Basic Materials
$58.31 +1.13%

+$0.81 today

Market cap
$1.97B
Beta
1.19
P/E (TTM)
-20.0
EPS (TTM)
-$3.62
52W Low $39.74High $79.29

Volume 0.37M

Average 0.26M

NGVT Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Ingevity CorporationNYSE: NGVT

Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026

Cost of revenue declines year over year

Q3 FY2026 cost of revenue of $172.3M fell 13.5% year over year, ahead of the -17.3% change in trailing-twelve-month cost of revenue. Sequentially, it fell 1.6% from the prior quarter. Over 3 fiscal years it compounded at -13.7% a year.

Context

  • Cost of revenue amounted to 60.5% of revenue in FY2025, down 7.2 pp from a year earlier.
  • Cost of revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -13.5% holds above the trailing-twelve-month pace of -17.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$172.3M-1.6% QoQ
Last fiscal yearDec 2025
$706.1M-25.8% YoY
LTMSep 2026
$656.3M-17.3% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-13.5%——
1 year-25.8%——
3-year CAGR-13.7%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
706.1M USD
Year-over-year change
-25.8%
4-year CAGR
-5.3%

Cost of Revenue vs competitors

How NGVT compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -17.3% is the 10th highest of 11, against a peer median of +2.8%.
  • Cost of revenue amounts to 58.0% of revenue for NGVT, versus a peer median of 72.5%.
NGVT Competitors
Cost of Revenue for NGVT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OLNOlin CorporationLTM Jun 2026$6.17B USD+1.4%-4.4%92.0%
CCThe Chemours CompanyLTM Jun 2026$4.91B USD+2.1%-2.0%84.7%
FMCFMC CorporationLTM Mar 2026$2.22B USD-11.7%-13.8%64.7%
MTXMinerals Technologies Inc.LTM Apr 2026$1.6B USD+3.5%-2.2%75.1%
IOSPInnospec Inc.LTM Jun 2026$1.34B USD+4.2%-2.3%72.5%
KWRQuaker Chemical CorporationLTM Sep 2026$1.32B USD+8.8%-3.1%65.0%
ASHAshland Inc.LTM Jun 2026$1.3B USD-5.9%-6.5%70.6%
AAUCAllied Gold CorporationLTM Jun 2026$834.64M USD+27.5%+19.2%56.1%
NGVTIngevity CorporationLTM Sep 2026$656.3M USD-17.3%-13.7%58.0%
ELVRElevra Lithium LimitedFY2025A$286.86M AUD+275.5%—138.4%
SKESkeena Resources LimitedLTM Sep 2026CA$1.35M CAD-51.1%+8.9%—
Peer median (excluding NGVT) —+2.8%-2.3%72.5%

Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.39B1.67B1.69B1.41B1.17B
Cost of Revenue878.7M1.1B1.22B951.7M706.1M
Gross Profit512.8M570.1M471.9M454.7M461.5M
Gross Margin36.9%34.2%27.9%32.3%39.5%
Research & Development26.3M30.3M31.8M28.1M28.4M
Selling, General & Admin179.3M198.8M183.7M166.7M171.2M
Operating Expenses205.6M229.1M215.5M194.8M199.6M
Depreciation & Amortization109.9M108.8M122.8M108.3M106.4M
EBITDA324.4M440.2M206M(329.5M)37.4M
EBITDA Margin23.3%26.4%12.2%-23.4%3.2%
Operating Income307.2M341M256.4M259.9M261.9M
Operating Margin22.1%20.4%15.2%18.5%22.4%
Interest Income4M5.8M6.3M6.9M4.4M
Interest Expense51.7M61.8M93.3M97.8M77.1M
Other Income / Expenses(144.4M)(71.4M)(266.5M)(795.5M)(404M)
Income Before Tax162.8M269.6M(10.1M)(535.6M)(142.1M)
Pre-Tax Margin11.7%16.2%-0.6%-38.1%-12.2%
Income Tax Expense44.7M58M(4.7M)(105.3M)8.2M
Net Income118.1M211.6M(5.4M)(430.3M)(167.1M)
Net Margin8.5%12.7%-0.3%-30.6%-14.3%
EPS (Basic)2.975.50(0.15)(11.85)(4.61)
EPS (Diluted)2.955.50(0.15)(11.85)(4.61)
Weighted Avg Shares39.8M38.47M36.5M36.32M36.2M
Weighted Avg Shares (Diluted)40.06M38.47M36.5M36.32M36.2M

Ingevity Corporation

NYSE:NGVT

Intrinsic Alpha fair value

Locked

Current Price

$58.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.